A detailed history of Insigneo Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Insigneo Advisory Services, LLC holds 4,480 shares of NVS stock, worth $479,718. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,480
Previous 4,792 6.51%
Holding current value
$479,718
Previous $464 Million 6.17%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $28,881 - $33,499
-312 Reduced 6.51%
4,480 $492 Million
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $21,531 - $24,514
226 Added 4.95%
4,792 $464 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $58,222 - $64,071
631 Added 16.04%
4,566 $461 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $58,258 - $64,654
615 Added 18.52%
3,935 $401 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $307,166 - $348,301
3,320 New
3,320 $335 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Insigneo Advisory Services, LLC Portfolio

Follow Insigneo Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insigneo Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insigneo Advisory Services, LLC with notifications on news.